Skip to main content

Table 3 Hematological and non-hematological toxicity(% patients)

From: A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

Toxicity

Grade 3

Grade 4

Anaemia

12

-

Neutropenia

24

8

Trombocytopenia

16

4

Neuropathy

-

-

Mucositis

-

-